false
Catalog
EP on EP Episode 88: Sudden Cardiac Death Trials - ...
EP on EP Episode 88: Sudden Cardiac Death Trials - ...
EP on EP Episode 88: Sudden Cardiac Death Trials - Past and Future with Jeanne E. Poole, MD, FHRS
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this episode of EP on EP, Dr. Jeannie Poole discusses the need for new trials in sudden cardiac death prevention. She highlights the changes in patient care and heart failure medications that have occurred since the old trials and emphasizes the importance of identifying patients at risk. Dr. Poole also debates the role of newer agents, such as Entresto and SGLT2 inhibitors, and the need for further trials to support their use in current guidelines. Furthermore, she discusses the role of scarred myocardium as a predictor of sudden cardiac death and expresses concern about boutique diseases, such as mitral valve prolapse, and the challenges they pose for trial design.
Keywords
sudden cardiac death prevention
patient care
heart failure medications
Entresto
risk identification
Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy
|
Cookie Declaration
|
Linking Policy
|
Patient Education Disclaimer
|
State Nonprofit Disclosures
|
FAQ
×
Please select your language
1
English